Fighting Treatment-Resistant Depression with Ketamine: Dr. Evyn Peters
Release Date: 11/12/2023
Not Just Numbers: Vaidehee Lanke Tracks Opiate Use & Perinatal Health
Researchers Under the Scope
In this episode, medical student and researcher shares what large provincial datasets reveal about opioid use disorder, maternal mental health, and pregnancy. Armed with data, she hopes better support —before, during, and after birth—can change outcomes for mothers and babies. Lanke spent her summer working with epidemiologist and the Saskatchewan Population Health and Evaluation Research Unit on a pan-Canadian project tracking opioid use in perinatal populations across five provinces. “The question we set out to answer was: What is the association between...
info_outline
Cross-Linked Clues: Jack Walther on Depression and Alzheimer's
Researchers Under the Scope
As a student, Jack Walther's friends often came to him when they needed a listening ear, or help with relationship struggles. This summer, Walther took his fascination with the brain and mood disorders to , learning to untangle some of the tiny molecular threads that might explain why depression so often shows up alongside dementia. Walther and the research team dug into the physical interactions between serotonin and the beta amyloid peptides that build up in patients with Alzheimer's disease. . He admits going from the classroom to the laboratory felt like a sharp learning curve. "It was...
info_outline
EEEV-ident Passion: Eve Simpson on Doubt, Persistence and Viral Spread
Researchers Under the Scope
Eve Simpson knows from experience scientific research doesn’t always follow a linear path. In the first of three student research episodes, the fourth-year biochemistry, microbiology and immunology student looks back at a summer spent decoding Eastern Equine Encephalitis Virus (EEEV) in ’s lab. Simpson said she loved doing bench research, but felt frustrated in the moments where she hit setbacks and moments of doubt. “I felt like I was letting everyone down,” she said. “But everyone I spoke to said they'd been through that. It's part of being a researcher. That's what drives us to do...
info_outline
That’s So Metal: Dr. Jessica Sheldon Targets Acinetobacter Baumannii
Researchers Under the Scope
Jessica Sheldon (PhD) is on a mission to starve out Acinetobacter baumannii —one of the world’s most virulent hospital-borne pathogens. Notorious for its speedy evolution and multi-drug resistance, the hospital-borne bacteria lingers on dry surfaces and infects critically-ill patients, leading to sepsis, pneumonia and high mortality rates. In this episode, delves into the real-life events that drove her to investigate histamine, and its role in bacterial survival and immune response. In 2022, Sheldon joined the University of Saskatchewan’s College of Medicine as an assistant professor...
info_outline
Fluid Endeavour: Kirk Haan's Medical Balancing Act
Researchers Under the Scope
Kirk Haan graduated from high school, thinking he’d study pharmacy at the University of Saskatchewan, and walk out five years later. After one summer at a pharmacy, Haan realized he was after a more ‘hands-on’ career in medicine. “I’ve kind of worked with my hands my whole life, just between rummaging around on a farm and always kind of building things,” he said. “Now it’s using them to help people in a direct way.” Then, Haan found his passion — inside the laboratory. In 2018, Haan landed a summer position in , studying osmoregulation — the mechanisms that govern...
info_outline
Dr. Sébastien Gauvrit: Fishing for Answers in Vascular Development
Researchers Under the Scope
Sébastien Gauvrit (PhD) was only ten when his family let him have his first tank of guppies. Within weeks, he was hooked. “I actually had to understand genetics directly by mixing these different fish together to get the colour or fin shape I was interested in,” said the vascular biologist and genetic modelling pioneer. From his home in France, to post-doctoral work pioneering new models for vascular disease in Germany, to his current position as an assistant professor of Anatomy, Physiology and Pharmacology at the University of Saskatchewan’s College of Medicine — tropical fish...
info_outline
Dr. Stu Skinner & Mobile Medicine: Halting Syphilis & HIV
Researchers Under the Scope
Stuart Skinner (MD) knew something was wrong three years ago, when patients started coming to him with vision loss, fever, rashes, and meningitis. Almost every case could be traced back to untreated syphilis — a sexually transmitted infection with caseloads exploding 1,200 per cent from 2017. Saskatchewan saw this spike just as Covid-19 entered the picture. “With the pandemic, testing dropped dramatically,” Skinner said, noting this , often travelling alongside HIV. Syphilis often spreads through sores, and can remain unnoticed for months or years on end, making early detection...
info_outline
Peptide Puzzle: Dr. Yi-Chun Chen on Early Markers for Diabetes and Obesity
Researchers Under the Scope
Yi-Chun Chen (PhD) is taking a close-up look at some of the body’s hardest-working cells — the ones often processing an overabundance of modern-day food and nutrients. “From an evolutionary point of view, our cells are not designed to deal with that,” said Chen, who joined the department of Anatomy, Physiology, and Pharmacology at the University of Saskatchewan last year as an assistant professor. She said our bodies are pushed into churning out large amounts of insulin rapidly after snacks and meals, “which makes the beta cells work extra hard.” Raised in Taiwan and inspired by...
info_outline
In the Trenches: Dr. James Stempien on Emergency Medicine
Researchers Under the Scope
James Stempien (MD) has navigated some of the most challenging corners of emergency medicine, from the frigid isolation of Inuvik to the bustling corridors of Saskatoon’s emergency departments. His experience in low-tech outposts has shaped his approach to modern emergency care. “When things aren’t going well you see it in the emergency department first,” Stempien said. “We’re the front door. We’re always open.” As provincial department head of emergency medicine, Stempien sees patients on their worst days in hospitals bursting at the seams, struggling to...
info_outline
All’s Not Lost: A Roadmap to Treating Hepatitis C on the Prairies
Researchers Under the Scope
As the world aims to eradicate hepatitis C (HCV) by 2030, Carrielynn Lund and Dr. Alexandra King’s team created a how-to guide. is a step-by-step guide to tackling a spike of new infections across the three Canadian prairie provinces. Hepatitis C (HCV) causes severe liver disease, and was notoriously difficult to treat until the introduction of direct-acting antivirals a decade ago — antivirals which boast a remarkable 95% success rate. Despite this advancement, Lund and Dr. King say Saskatchewan, Alberta and Manitoba need to know why HCV cases keep rising, particularly in...
info_outlineDr. Evyn Peters has created pivotal changes for patients arriving at Royal University Hospital's mental health short stay unit, and its emergency department.
With 33 publications and interests spanning psychiatry, psychopharmacology and mood disorders, Peters is often one of the first physicians patients see when they’re experiencing a mental health crisis.
Peters was finishing his residency at RUH and the University of Saskatchewan’s College of Medicine in 2017, when he and his colleagues first proposed ketamine for short-stay patients who had tried multiple antidepressants without success.
After studying best practices in other centres, Peters and his colleagues developed a protocol to treat patients with a ketamine nasal spray. His patients stay conscious, and don’t need an intravenous catheter or intensive cardiorespiratory monitoring.
“Not only does it work very quickly but it is twice as effective roughly as your conventional anti-depressants. And what’s more impressive is that it’s being used for patients typically who’ve failed to respond to anti-depressants in the past,” Peters said.
“It certainly is a cost-effective treatment.”
Until 2020, the only other option for hospitalized patients who didn’t respond to other drugs was electroconvulsive therapy (ECT).
Hospitals in Saskatchewan sometimes struggle with backlogs, with patients waiting weeks for ECT. A psychiatrist and anesthetist and nurses must oversee the procedures, including treatments which typically stretch over another four weeks.
“That’s a long time in hospital,” said Peters. “You can get a similar response rate with one or three or four ketamine treatments every second day in about a week in hospital here.”
Peters was the lead author on the 2023 article Intranasal racemic ketamine for patients hospitalized with treatment-resistant depression: A retrospective analysis, published earlier this year in the journal Experimental and Clinical Psychopharmacology, together with his University of Saskatchewan psychiatry colleagues Dr. Katelyn Halpape, Dr. Isaac Cheveldae and Dr. Annabelle Wanson.
His patients, on average, were taking 3.5 psychiatric medications when they were admitted. His team made a point of not requiring patients to wean themselves off other anti-depressants during their treatment with ketamine.
“We have a response rate in the hospital here of about 65 per cent, which is what you see in other treatment centres” said Peters. “The vast majority of those patients, about 75-80% get discharged immediately after that treatment.”
He said the rest of his patients often face other health and life circumstances complicating their discharge, such as homelessness. On top of that, ketamine is not suitable for anyone who’s recently had a heart attack, stroke, blood pressure issues, or who has schizophrenia.
“The goal was just to get it in use, because it was needed,” said Peters. “Now we can answer some of these questions about why does it work, and for whom does it work the best?”